rfhg_112371.1

Basic information about the TSS

---

TSS ID: rfhg_112371.1 Species: human Chr: chr8		Start: 143592115 End: 143592131 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000528519.1:-38 GeneID: 1936 HGNC/MGI_ID: HGNC:3211 UniProt_ID: E9PPY1 Nearer transcript ids and distances:

Gene_name: eukaryotic translation elongation factor 1 delta Gene_symbol: EEF1D Gene_synonyms: EF-1D FLJ20897 Gene_source: HGNC:3211

TATA-Box annotation

---

Distance to TSS:	5290
Nearest PromoterID:	NM_001130057
Entrez ID:	1936
Nearest Unigene:	Hs.333388
Nearest Refseq:	NM_001960
Nearest Ensembl:	ENSG00000104529
Gene Name:	eukaryotic translation elongation factor 1 delta
Gene Alias:	EF-1D|EF1D|FP1047
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.705882
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EEF1D p2@EEF1D p3@EEF1D p4@EEF1D p5@EEF1D p6@EEF1D
Sample		p1@EEF1D	p2@EEF1D	p3@EEF1D	p4@EEF1D	p5@EEF1D	p6@EEF1D
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	102.47	4.68	1.36	3.51	2.14	3.70
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	104.19	3.24	0.20	3.44	2.63	2.63
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	113.81	5.02	1.74	3.86	2.51	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	104.79	4.57	0.42	2.29	1.46	3.53
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	111.58	2.70	1.35	3.82	2.47	3.60
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	110.08	5.23	0.39	2.52	1.55	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	131.38	3.70	1.74	5.01	2.40	2.18
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	109.48	5.33	0.00	3.88	1.70	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	108.35	4.27	0.64	2.14	3.42	3.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	109.55	3.48	1.74	3.48	4.06	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	102.68	2.43	0.81	2.83	1.62	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	74.81	2.85	0.00	2.85	1.22	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	62.38	3.22	3.87	2.10	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	69.76	2.56	3.76	2.10	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	60.82	2.85	3.95	2.20	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	60.36	2.77	2.51	1.51	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	73.60	3.49	2.18	1.75	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	64.54	2.11	2.11	1.27	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	97.57	2.67	2.13	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	65.89	4.21	4.51	3.16	0.90	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	70.17	3.07	2.81	1.20	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	74.75	2.93	3.45	2.42	0.52	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	70.70	3.10	2.46	1.81	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	82.02	2.91	4.37	3.15	1.21	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	73.27	1.81	1.55	2.58	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	76.28	3.17	1.90	0.63	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	70.88	2.75	2.75	2.75	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	87.70	4.48	3.77	2.59	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	73.01	3.39	2.91	2.42	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	80.53	3.08	3.80	1.63	0.90	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	76.62	2.72	4.40	3.77	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	67.99	3.32	3.71	2.15	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	73.65	3.38	2.74	0.63	1.06	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	97.64	4.29	1.15	1.98	0.82	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	68.81	3.55	3.18	2.43	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	77.42	4.22	5.94	1.72	0.96	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	81.96	2.45	4.09	2.04	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	81.80	4.43	3.43	1.81	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	75.09	3.78	3.78	1.62	0.27	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	65.54	3.12	2.16	2.64	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	84.93	4.00	2.82	1.41	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	89.89	3.66	1.76	1.61	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	56.31	5.06	4.85	2.11	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	70.11	3.85	4.02	0.52	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	56.22	3.61	4.22	2.41	1.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	58.16	1.86	2.33	1.40	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	64.05	4.56	3.36	3.12	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	59.01	1.79	4.77	1.49	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	70.38	3.35	2.15	1.20	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	58.84	4.25	2.83	2.02	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	55.13	3.48	3.07	2.66	1.23	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	72.94	3.34	2.00	2.00	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	68.84	2.84	1.42	1.42	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	69.59	4.64	3.31	0.99	1.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	83.05	6.71	1.68	2.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	76.69	4.13	0.92	0.92	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	56.07	2.59	1.62	1.30	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	58.45	1.61	2.89	1.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	75.12	4.09	2.20	1.57	0.94	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	76.85	2.82	4.94	0.00	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	68.42	6.17	2.80	0.56	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	39.81	2.39	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	63.20	2.04	1.36	1.02	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	51.34	3.90	1.95	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	58.93	4.26	2.13	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	0.00	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	15.79	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	60.94	4.88	1.46	0.00	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	54.55	3.97	1.49	1.49	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	49.26	2.81	1.88	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	50.67	3.31	0.33	1.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	53.21	1.86	2.17	1.24	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	56.87	4.59	3.36	1.83	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	77.61	4.28	1.90	1.90	0.48	0.48
Adipocyte - breast, donor2	11327-117E4	70.75	5.78	1.93	0.64	0.48	0.32
Adipocyte - omental, donor1	11473-119C6	75.83	6.62	0.76	1.02	0.25	1.02
Adipocyte - omental, donor2	11474-119C7	87.46	4.48	0.75	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	114.21	7.37	1.67	2.01	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	129.51	9.57	1.91	1.91	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	136.34	5.50	1.10	1.10	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	103.87	4.52	2.71	4.97	1.81	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	182.99	4.69	3.65	2.09	1.04	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	72.56	6.06	2.15	1.17	0.20	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	60.48	3.09	1.29	1.80	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	66.07	1.67	0.00	1.67	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	49.96	1.76	1.18	1.76	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	95.80	3.94	1.37	0.88	0.97	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	63.58	3.23	0.65	1.94	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	69.31	1.60	0.53	1.60	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	62.32	3.34	1.11	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	74.03	3.74	0.00	0.42	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	58.52	3.77	1.00	0.25	2.01	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	41.89	1.96	0.98	0.98	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	24.97	2.13	1.22	0.30	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	166.19	8.18	2.65	1.55	1.55	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	413.44	15.06	3.94	2.51	3.59	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	172.51	7.19	3.59	2.40	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	172.17	7.92	0.18	0.18	1.62	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	215.88	6.69	1.67	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	181.20	10.27	2.05	1.03	2.47	1.03
Anulus Pulposus Cell, donor1	11248-116E6	149.67	10.76	2.40	1.37	0.34	0.11
Anulus Pulposus Cell, donor2	11463-119B5	101.15	9.31	2.45	1.47	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	117.27	6.74	1.35	4.94	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	130.24	8.68	3.04	1.74	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	107.01	10.70	4.28	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	118.67	9.57	2.39	3.59	1.49	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	120.14	13.91	1.26	5.06	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	104.95	5.28	1.98	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	109.49	7.80	2.27	4.22	1.30	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	133.98	10.19	1.94	3.88	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	125.90	3.56	1.19	6.53	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	118.64	9.04	2.26	7.53	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	113.21	5.81	2.18	0.73	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	122.87	10.03	2.51	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	135.08	8.24	2.47	2.80	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	94.17	9.55	2.73	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	75.40	5.88	1.96	2.56	0.60	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	106.09	7.50	3.21	3.21	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	109.02	6.99	3.78	3.97	0.38	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	114.40	7.75	1.34	3.47	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	78.04	8.78	1.95	2.93	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	107.15	9.95	3.48	3.65	0.83	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	103.26	6.00	1.20	6.00	1.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	10.62	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	112.18	8.92	2.23	3.77	1.03	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	104.87	8.39	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	120.87	8.25	2.91	3.40	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	127.88	9.49	4.17	3.04	0.76	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	87.22	6.06	2.42	2.42	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	121.42	9.69	1.71	3.42	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	123.56	7.70	3.85	0.86	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	106.07	6.71	2.06	4.13	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	131.38	10.32	1.88	2.35	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	107.08	7.72	1.61	3.22	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	116.29	7.13	0.71	0.71	0.71	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	135.71	7.60	0.58	2.34	2.92	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	101.16	3.61	2.11	3.61	1.20	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	131.87	14.26	2.38	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	134.77	6.10	2.03	3.56	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	96.78	6.62	2.29	3.06	2.04	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	102.93	8.90	1.27	7.62	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	117.81	6.90	2.16	4.32	1.29	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	112.19	6.35	2.96	2.12	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	104.97	5.51	1.74	3.19	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	89.75	10.39	0.94	3.78	0.94	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	99.51	7.80	3.05	2.71	0.68	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	122.77	16.21	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	90.84	6.34	6.34	6.34	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	102.06	6.00	3.22	2.57	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	122.14	6.02	3.61	3.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	105.70	10.93	3.64	4.37	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	122.99	11.03	3.68	2.30	0.69	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	102.01	5.10	5.10	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	67.12	5.85	3.56	2.03	1.78	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	119.94	8.26	4.54	3.30	1.24	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	108.32	7.34	1.84	2.14	0.92	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	134.32	8.13	2.39	5.26	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	119.74	4.43	2.88	1.55	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	108.33	3.05	1.53	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	118.53	7.20	2.22	2.77	2.22	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	100.89	5.83	3.18	2.91	1.59	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	107.94	9.09	1.09	1.09	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	181.89	14.37	1.84	1.23	1.97	1.60
Astrocyte - cerebellum, donor2	11580-120F5	218.40	14.72	2.74	3.77	1.88	0.86
Astrocyte - cerebellum, donor3	11661-122F5	178.29	13.00	0.84	1.89	1.89	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	160.00	8.71	1.74	1.39	1.39	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	152.23	7.93	1.29	1.78	1.62	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	151.70	11.04	1.64	1.34	1.64	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	144.27	18.35	1.83	0.34	0.69	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	145.08	16.66	1.75	0.50	1.38	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	133.71	14.11	1.71	0.46	1.14	0.46
Basophils, donor1	12241-129G9	139.40	6.28	0.00	0.52	0.26	0.00
Basophils, donor2	12242-129H1	167.05	5.77	0.00	0.00	0.72	0.00
Basophils, donor3	12243-129H2	154.64	9.70	0.00	0.00	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	150.28	5.82	2.59	3.23	0.86	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	329.63	16.92	6.40	2.29	1.37	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	179.34	7.17	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	200.22	9.41	3.14	4.39	4.39	8.79
Bronchial Epithelial Cell, donor5	11457-119A8	192.77	10.40	6.65	4.16	3.54	2.70
Bronchial Epithelial Cell, donor6	11461-119B3	201.96	9.44	2.30	2.30	0.92	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	124.88	3.96	4.68	3.42	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	196.84	3.61	0.93	0.10	0.41	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	143.24	11.18	4.66	2.33	0.93	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	233.44	9.91	0.96	0.64	1.28	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	341.28	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	141.45	10.71	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	120.27	10.39	0.00	0.19	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	145.55	11.42	0.00	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	121.14	4.25	0.00	0.00	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	98.18	4.55	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	100.92	3.94	0.00	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	137.76	9.40	0.14	0.00	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	89.32	4.53	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	82.68	5.69	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	110.32	8.87	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	69.28	7.73	0.28	0.00	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	96.20	6.20	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	117.48	10.38	0.00	0.20	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	107.54	7.30	0.00	0.36	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	116.43	7.40	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	111.44	11.47	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	111.41	9.50	0.00	0.53	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	143.11	8.87	0.00	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	117.66	9.97	0.00	0.00	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	87.80	4.99	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	96.60	6.66	0.00	0.00	0.62	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	112.79	7.55	0.00	0.00	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	79.17	9.50	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	82.49	5.24	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	108.13	12.64	0.27	0.27	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	124.56	8.37	0.00	0.17	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	94.26	4.63	0.00	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	102.14	10.10	0.18	0.00	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	75.74	8.45	0.00	0.35	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	74.58	7.02	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	105.50	9.59	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	83.63	5.95	0.00	0.37	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	124.59	10.35	0.00	0.22	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	95.82	12.28	0.82	0.41	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	79.51	5.10	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	104.16	7.19	0.00	0.00	0.70	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	141.68	9.15	0.00	0.22	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	205.82	6.93	0.23	0.00	0.46	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	167.23	9.10	0.22	0.22	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	242.93	12.15	0.31	0.16	0.47	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	206.60	12.05	0.00	0.00	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	85.84	6.24	0.22	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	268.95	9.44	0.00	0.00	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	239.55	10.76	0.00	0.00	0.66	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	182.12	6.95	0.00	0.42	0.84	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	398.33	12.19	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	378.31	8.81	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	388.35	10.36	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	535.70	6.93	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	477.64	6.97	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	386.77	7.72	0.00	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	431.40	12.55	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	427.12	3.95	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	334.51	9.86	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	352.56	7.98	0.73	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	341.77	5.55	1.51	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	134.15	20.20	1.21	0.00	0.40	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	136.23	11.19	0.00	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	173.70	6.02	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	202.81	10.11	1.12	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	230.34	6.76	0.38	0.75	3.01	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	227.96	9.92	1.13	1.13	0.45	0.68
CD4+ T Cells, donor1	11225-116C1	457.39	9.28	0.00	0.36	0.71	0.71
CD4+ T Cells, donor2	11306-117C1	436.61	13.47	1.22	0.61	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	402.90	12.20	0.00	0.30	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	212.87	9.95	0.26	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	232.01	10.78	1.12	0.22	1.12	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	209.85	10.06	1.15	0.57	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	814.01	11.85	0.00	0.00	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1180.60	11.24	0.00	0.70	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	735.06	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	152.61	13.15	0.14	0.14	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	144.55	10.51	0.34	0.34	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	117.52	10.80	0.48	0.64	0.48	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	392.71	11.21	0.00	0.00	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	518.49	13.28	0.00	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	282.91	7.48	0.88	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	153.90	10.96	0.00	0.00	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	150.43	9.56	0.00	0.00	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	150.69	10.36	0.00	0.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	684.46	11.15	0.00	0.27	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	731.57	12.33	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	557.69	10.76	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	168.93	15.39	0.19	0.19	0.56	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	159.43	13.21	0.00	0.22	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	137.23	15.55	0.21	0.00	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	579.42	19.72	0.00	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	702.30	12.13	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	297.66	6.54	0.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	497.34	11.38	0.49	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	549.30	9.23	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	505.29	15.35	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	503.46	8.58	0.55	0.00	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	442.69	11.78	0.00	0.25	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	411.18	7.70	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	503.16	12.18	0.72	0.00	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	563.69	19.39	1.38	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	391.57	10.15	0.00	0.33	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	321.75	11.26	0.75	0.75	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	414.08	12.88	0.00	0.76	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	75.47	8.26	0.69	0.46	1.61	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	79.08	4.79	0.24	0.48	1.20	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	78.52	6.84	0.55	1.09	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	99.97	8.71	0.90	1.20	0.90	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	70.55	6.00	0.24	0.48	2.64	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	72.99	5.23	1.14	0.91	2.05	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	89.52	6.08	0.43	0.65	1.96	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	88.44	7.37	0.79	1.05	2.11	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	82.31	4.69	0.70	0.47	1.41	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	80.90	5.74	1.21	0.30	0.91	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	90.93	3.78	0.58	1.45	1.16	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	69.81	6.93	1.07	1.07	1.33	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	50.34	2.19	0.88	0.44	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	60.57	2.28	0.00	0.00	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.02	2.24	0.00	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	83.56	4.32	0.72	1.08	1.80	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	72.51	5.18	0.86	0.86	1.73	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	67.88	5.66	0.24	1.65	0.47	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	70.67	8.56	0.95	1.58	2.85	2.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	80.58	6.77	1.85	1.23	3.69	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	65.40	5.45	0.64	0.64	1.60	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	77.64	8.41	0.76	0.38	1.91	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	59.12	4.34	1.18	1.18	1.18	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	62.03	3.78	0.76	0.00	0.76	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	67.45	6.42	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	57.35	3.50	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	63.11	3.01	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	18.28	0.00	3.66	3.66	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	150.20	6.42	1.48	0.99	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	166.37	6.73	1.89	2.42	0.53	0.32
Chondrocyte - de diff, donor1	11261-116G1	94.29	7.28	2.77	1.73	0.00	2.43
Chondrocyte - de diff, donor2	11338-117F6	134.69	5.69	0.71	0.71	1.07	0.36
Chondrocyte - de diff, donor3	11410-118E6	153.94	8.99	2.05	1.37	0.57	0.57
Chondrocyte - re diff, donor2	11339-117F7	118.17	6.27	3.58	0.90	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	120.51	5.26	2.83	0.81	1.62	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	147.23	12.16	0.57	0.92	0.34	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	121.42	8.12	3.21	3.85	1.50	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	123.90	8.50	2.30	2.04	1.15	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	120.31	7.15	0.64	0.55	0.64	0.18
Corneal Epithelial Cells, donor1	11526-119I5	187.51	9.66	5.49	2.20	1.10	0.88
Corneal Epithelial Cells, donor2	11606-120I4	145.61	6.83	2.28	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	173.83	12.53	5.88	3.58	2.05	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	43.75	3.96	0.17	0.00	0.99	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	42.90	3.78	0.32	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	40.60	8.75	0.22	0.11	0.97	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	201.23	11.62	0.00	0.68	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	228.50	15.67	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	209.06	17.91	0.00	0.00	1.45	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	147.76	5.67	1.33	0.67	0.67	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	108.55	8.80	1.76	2.93	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	117.36	6.22	2.55	1.13	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	108.91	5.11	2.36	1.57	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	98.90	3.49	2.33	0.87	0.87	0.58
Endothelial Cells - Artery, donor2	11341-117F9	122.58	5.41	1.65	1.88	0.24	2.35
Endothelial Cells - Artery, donor3	11413-118E9	139.55	7.36	1.75	2.80	1.23	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	83.34	4.43	1.33	1.33	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	52.64	4.87	3.65	0.61	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	57.51	2.82	1.97	1.41	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	118.85	7.43	0.89	0.30	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	96.84	2.60	1.56	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	151.85	5.53	0.99	0.71	0.85	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	104.83	4.80	1.20	1.20	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	98.01	5.24	3.14	1.57	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	129.09	6.96	1.86	1.12	0.62	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	68.44	5.87	2.17	1.30	0.22	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	81.21	4.64	1.22	1.95	0.61	0.37
Endothelial Cells - Vein, donor1	11267-116G7	123.99	4.55	0.00	1.14	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	96.39	4.19	0.70	2.10	1.40	1.40
Endothelial Cells - Vein, donor3	11416-118F3	122.78	6.12	1.41	2.04	0.31	0.16
Eosinophils, donor1	12244-129H3	365.93	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	272.29	4.95	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	214.01	7.13	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	140.73	8.55	1.95	0.49	0.98	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	164.33	8.32	12.48	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	48.81	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	56.24	5.34	1.64	4.93	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	59.78	3.72	2.08	3.18	1.20	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	104.87	5.42	2.06	2.28	0.76	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	142.38	7.76	1.70	4.37	1.70	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	68.51	4.91	2.46	4.91	0.82	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	114.33	6.54	2.32	2.64	0.53	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	97.75	6.32	0.79	3.43	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	117.60	7.64	2.33	1.66	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	123.39	8.17	3.63	8.62	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	126.58	6.82	2.27	4.55	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	138.32	10.88	2.68	4.26	1.58	1.26
Fibroblast - Cardiac, donor4	11452-119A3	80.63	4.85	2.12	1.52	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	114.09	6.22	2.79	1.65	1.14	0.38
Fibroblast - Cardiac, donor6	11460-119B2	123.55	6.67	2.43	3.49	1.06	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	142.16	11.39	1.88	2.55	1.21	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	86.29	4.75	2.59	3.02	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	131.83	4.39	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	108.63	11.76	1.61	0.92	1.38	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	189.11	8.65	1.19	1.36	0.85	0.34
Fibroblast - Dermal, donor1	11269-116G9	84.29	6.57	6.57	6.81	1.41	1.41
Fibroblast - Dermal, donor2	11346-117G5	134.90	7.55	3.77	5.66	1.42	1.42
Fibroblast - Dermal, donor3	11418-118F5	128.99	10.40	5.92	6.04	0.73	0.36
Fibroblast - Dermal, donor4	11450-119A1	129.10	7.91	3.05	3.28	1.58	0.57
Fibroblast - Dermal, donor5	11454-119A5	145.49	8.55	3.49	3.49	0.52	0.70
Fibroblast - Dermal, donor6	11458-119A9	147.16	9.58	2.27	3.41	1.30	0.81
Fibroblast - Gingival, donor1	11237-116D4	121.40	8.33	3.96	2.08	0.83	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	90.91	7.60	2.10	0.26	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	142.46	12.39	2.64	2.24	1.19	1.05
Fibroblast - Gingival, donor3	11394-118C8	140.68	6.86	3.38	1.64	1.06	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	51.94	10.39	0.00	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	74.01	6.17	1.06	0.88	0.70	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	123.47	8.57	1.71	2.34	1.25	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	112.51	10.82	1.62	1.89	0.81	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	52.93	2.82	0.00	1.06	0.71	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	88.62	7.02	2.49	2.34	1.02	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	100.77	5.45	0.95	2.18	0.68	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	94.77	7.02	1.10	2.52	1.10	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	97.73	3.23	1.17	1.32	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	103.31	4.08	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	105.94	4.48	4.48	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	131.69	15.62	2.53	3.59	1.06	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	204.09	9.16	2.50	5.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	149.65	9.79	2.80	5.59	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	124.54	12.03	1.96	2.24	1.12	0.84
Fibroblast - Mammary, donor1	11540-120B1	178.63	9.74	4.47	1.62	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	187.73	3.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	166.78	11.91	0.00	5.96	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	145.87	8.92	1.55	1.75	1.16	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	150.62	8.95	1.82	1.97	0.91	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	86.59	4.28	3.67	1.22	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	72.13	5.72	1.91	2.29	0.38	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	118.80	12.96	1.62	1.35	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	62.97	5.68	0.46	0.93	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	144.36	8.84	2.76	2.65	1.44	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	145.28	13.00	2.03	1.22	1.22	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	134.31	10.69	1.34	2.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	162.89	11.07	1.98	3.95	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	120.46	8.33	0.99	3.18	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	96.98	4.09	1.07	1.07	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	93.22	5.91	1.97	1.38	0.39	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	150.73	7.82	2.41	2.11	1.20	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	110.87	7.12	0.54	1.62	0.43	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	94.14	10.12	2.78	4.56	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	105.50	6.56	1.80	1.48	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	96.44	5.01	1.40	1.60	0.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	95.24	6.73	1.41	1.81	0.70	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	126.94	6.65	1.21	1.81	1.81	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	151.19	5.05	1.08	0.91	0.83	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	142.57	6.15	1.71	1.03	0.85	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	88.68	7.55	2.30	1.97	0.33	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	101.20	9.27	1.81	1.28	0.75	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	109.98	7.59	3.37	1.86	1.35	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	133.61	6.43	1.57	1.41	0.47	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	67.98	6.97	2.61	6.10	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	109.56	5.37	1.56	2.08	1.91	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	95.51	8.33	4.94	1.30	1.56	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	69.75	3.83	3.32	2.81	2.04	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	124.02	8.42	3.06	2.30	1.53	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	142.29	11.49	1.28	3.19	3.19	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	135.50	11.13	7.70	4.28	2.57	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	90.72	13.24	3.31	0.55	0.55	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	64.39	8.22	1.14	1.14	2.97	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	87.97	10.90	6.34	2.77	1.19	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	83.27	14.01	3.70	1.85	1.32	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	60.66	10.11	1.30	0.65	1.96	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	89.33	10.61	1.33	1.33	4.42	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	127.05	14.56	2.12	1.55	1.13	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	125.61	12.56	2.46	3.08	1.72	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	111.75	11.55	1.07	0.81	0.54	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	137.77	11.89	1.86	1.24	1.61	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	151.85	13.15	2.21	1.80	0.69	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	95.96	7.12	1.22	1.63	1.22	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	109.53	6.62	1.14	1.60	1.60	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	117.34	7.97	2.37	2.24	0.87	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	69.73	4.59	2.62	1.09	1.53	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	123.51	6.50	3.84	0.59	1.77	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	133.37	12.56	1.27	0.79	1.27	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	93.61	5.81	0.89	0.89	0.89	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	134.09	11.29	0.81	0.81	1.41	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	151.49	11.54	1.70	1.19	1.19	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	98.43	5.94	1.86	1.33	0.71	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	145.26	8.84	1.98	1.35	0.52	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	145.84	6.49	1.02	0.68	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	136.99	11.51	1.55	0.89	0.55	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	108.57	5.74	1.08	1.08	1.00	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	87.59	5.72	1.63	0.82	0.61	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	134.10	9.90	0.62	1.44	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	140.43	9.80	1.61	1.38	0.81	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	105.40	8.34	1.00	2.17	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	117.71	7.05	1.10	1.10	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	167.15	8.86	0.74	1.72	1.48	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	98.55	8.59	1.46	1.62	1.46	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	129.57	5.77	1.92	0.64	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	117.59	9.66	0.47	1.33	0.47	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	96.96	7.75	0.63	0.95	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	101.87	6.39	0.00	0.61	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	124.40	10.87	0.73	0.84	1.36	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	87.60	7.03	1.98	0.88	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	91.74	6.17	0.84	0.56	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	63.51	6.76	1.57	1.67	0.83	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	78.35	7.22	1.34	1.34	0.80	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	68.24	7.80	1.68	1.38	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	93.78	9.84	1.55	2.07	1.55	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	67.50	6.78	1.36	1.90	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	93.47	7.74	1.29	2.21	1.11	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	95.40	6.36	1.97	1.97	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	79.34	3.97	3.97	1.98	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	98.14	7.65	1.58	1.71	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	89.58	7.06	2.22	1.41	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	56.17	1.78	2.03	1.52	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	111.27	12.14	4.18	1.99	1.00	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	120.18	18.80	5.70	3.08	1.54	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	158.35	18.41	5.11	3.68	2.05	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	129.55	10.33	2.19	1.88	2.82	3.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	124.89	8.48	2.54	1.41	3.11	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	79.33	6.92	8.76	5.53	1.84	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	108.89	4.95	2.47	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	109.08	11.60	3.09	3.09	2.32	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	72.20	9.63	1.60	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	111.29	17.39	3.48	1.74	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	116.85	10.42	3.91	2.60	2.28	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	111.60	9.06	0.82	1.24	2.47	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	113.30	6.66	3.33	6.66	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	113.26	6.71	2.24	0.84	1.40	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	101.98	11.44	2.61	2.29	2.61	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	124.99	11.74	5.87	2.52	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	131.05	12.09	1.27	2.54	1.59	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	114.47	8.15	2.72	3.74	1.36	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	179.58	14.62	0.00	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	166.08	13.17	1.72	1.72	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	127.86	7.10	2.37	1.48	2.37	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	101.65	18.64	5.08	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	143.32	12.84	0.83	0.00	2.90	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	110.00	12.20	2.99	0.69	2.07	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	15.81	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	127.24	10.76	0.77	1.15	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	125.82	10.76	0.98	1.96	2.61	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	130.42	8.03	1.34	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	192.63	17.72	1.16	1.93	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	144.47	10.95	3.08	4.11	2.40	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	141.63	14.91	9.94	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	144.86	6.61	2.83	2.83	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	150.87	8.45	3.62	3.62	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	181.09	10.17	3.56	3.56	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	159.54	12.76	1.99	3.19	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	182.54	9.37	0.99	3.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	134.57	15.35	4.72	4.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	180.87	15.75	1.17	1.17	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	170.73	7.46	4.83	2.63	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	112.74	8.48	1.70	1.70	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	91.33	7.76	1.19	4.18	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	131.50	16.98	0.49	0.97	1.46	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	114.13	9.13	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	96.89	8.73	0.83	0.83	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	187.78	10.12	0.00	0.00	2.25	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	133.52	4.44	1.59	2.85	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	128.66	7.94	1.25	3.76	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	167.33	16.59	3.71	2.67	2.79	2.09
Hep-2 cells mock treated, biol_rep2	11899-125E9	134.03	13.50	2.36	2.36	4.05	2.87
Hep-2 cells mock treated, biol_rep3	11900-125F1	135.14	15.24	3.87	3.19	4.10	2.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	185.72	16.51	2.30	2.30	2.62	1.97
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	139.69	13.11	2.15	2.36	5.16	1.72
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	120.34	12.06	2.37	1.29	4.74	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	184.94	17.68	3.24	2.49	2.86	1.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	123.52	16.13	2.40	2.23	3.43	1.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	110.53	14.42	1.92	1.92	1.92	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	102.97	9.51	0.56	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	134.60	9.52	2.60	3.03	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	60.81	5.29	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	144.62	7.76	1.76	3.53	0.71	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	140.22	7.99	2.91	6.54	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	119.24	7.17	2.10	3.67	2.97	1.40
Hepatocyte, donor1	11523-119I2	93.22	9.68	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	140.05	7.54	1.08	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	91.42	5.52	0.61	0.61	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	202.33	18.93	2.61	1.31	1.96	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	105.22	2.80	1.40	0.87	0.87	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	102.36	7.13	1.92	1.23	0.27	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	22.29	3.18	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	20.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	92.75	19.38	4.15	2.77	1.38	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	115.12	25.03	5.01	2.50	5.01	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	47.47	0.00	0.00	0.00	35.60
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	66.64	25.63	0.00	5.13	2.56	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	118.84	36.57	4.57	9.14	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	89.34	24.36	8.12	8.12	6.50	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	75.03	30.01	8.34	3.33	3.33	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	83.50	25.41	0.00	7.26	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	82.06	35.73	13.23	11.91	7.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	89.80	18.85	7.76	5.54	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	73.34	26.19	0.00	10.48	0.00	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	107.08	25.19	5.67	6.93	3.78	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	94.34	35.57	4.64	4.64	6.19	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	123.39	27.78	7.75	2.58	2.58	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	90.16	28.98	6.44	3.22	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	11.95	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	127.94	30.97	9.78	6.52	1.63	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	112.93	31.91	3.78	5.04	2.52	3.36
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	109.30	28.93	9.64	2.41	4.82	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	81.25	16.62	4.62	8.31	4.62	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	129.34	28.79	7.55	5.66	1.42	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	78.91	23.58	6.35	4.53	2.72	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	136.67	37.66	10.76	3.23	3.23	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	95.28	31.76	3.81	6.35	5.08	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	16.43	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	108.41	31.25	10.20	5.10	1.28	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	89.31	20.05	3.65	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	108.54	31.42	6.43	10.00	5.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	29.86	0.00	9.95	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	122.54	32.10	6.48	6.17	2.16	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	87.80	19.32	3.51	3.51	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	12.57	3.14	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	94.57	23.64	6.26	11.82	4.17	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	121.72	42.05	2.21	4.43	8.85	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	113.47	9.73	9.73	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	124.69	34.01	5.23	3.49	0.87	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	92.24	29.25	2.25	4.50	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	31.36	3.48	13.94	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	117.35	23.47	3.20	3.20	2.13	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	92.82	16.63	8.31	1.39	5.54	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	105.44	25.65	8.55	2.85	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	143.59	34.06	7.36	7.36	1.84	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	130.09	39.33	9.08	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	80.71	18.63	6.21	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	131.11	27.49	2.11	1.06	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	126.97	6.45	4.00	1.96	1.39	0.90
Keratinocyte - epidermal, donor2	11349-117G8	182.13	11.13	3.51	2.34	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	168.77	8.61	1.61	1.51	0.57	0.66
Keratinocyte - oral, donor1	11251-116E9	198.54	8.97	3.75	1.82	0.45	0.57
Keratocytes, donor1	11527-119I6	105.21	16.50	1.03	1.03	1.72	1.03
Keratocytes, donor2	11607-120I5	157.02	7.03	1.17	2.34	4.69	2.34
Keratocytes, donor3	11688-122I5	66.59	7.90	0.59	1.98	0.20	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	122.98	7.55	2.16	3.24	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	134.25	9.69	1.04	0.46	0.23	0.46
Lens Epithelial Cells, donor3	11690-122I7	73.26	5.65	3.83	2.22	0.91	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	106.24	9.13	1.07	0.36	0.47	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	111.07	5.30	0.00	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	111.13	5.82	0.79	1.42	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	87.65	6.99	0.54	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	108.10	4.10	0.32	0.95	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	110.08	5.39	0.65	1.62	0.54	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	87.41	4.51	0.82	1.23	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	129.70	10.37	0.76	0.76	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	117.67	7.32	0.42	0.99	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	83.46	7.52	0.00	2.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	111.68	7.17	0.97	0.97	0.19	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	136.08	7.22	0.74	1.85	0.56	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	85.71	5.92	0.70	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	119.74	6.20	0.48	0.72	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	113.45	7.28	1.10	0.69	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	86.23	4.93	0.62	1.23	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	126.88	9.66	0.62	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	139.07	8.42	1.10	1.10	0.55	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	79.97	5.59	1.32	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	126.52	9.96	0.29	0.29	0.00	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	154.58	10.21	0.50	1.24	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	96.99	4.85	1.94	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	123.07	7.81	0.81	1.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	116.56	8.48	0.91	1.36	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	91.24	4.67	1.56	1.04	0.52	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	114.96	6.49	1.05	1.26	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	107.97	6.77	0.60	0.60	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	95.61	4.13	0.00	2.75	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	119.85	8.09	0.38	0.75	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	122.15	8.27	0.53	0.64	0.42	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	96.43	4.85	1.94	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	116.44	4.96	1.32	1.32	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	110.88	7.68	1.49	0.74	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	92.55	4.81	1.48	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	118.85	5.93	0.49	0.99	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	118.79	7.84	0.96	1.24	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	92.95	4.82	0.96	2.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	119.91	8.52	0.61	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	116.87	7.42	0.98	0.56	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	85.33	6.04	1.78	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	120.22	6.30	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	148.29	11.20	1.09	0.47	0.62	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	102.42	5.73	1.07	0.72	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	115.32	8.49	0.00	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	120.77	9.65	0.94	1.18	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	97.27	6.56	1.36	1.11	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	123.45	6.15	0.00	0.77	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	99.05	6.86	0.60	0.30	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	237.93	11.33	4.53	2.27	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	328.33	12.27	2.30	5.37	8.44	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	281.30	10.39	0.74	3.71	6.68	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	339.35	6.77	1.69	4.65	4.23	4.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	353.77	9.85	0.00	4.22	4.92	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	304.47	2.80	0.00	0.93	3.74	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	318.95	5.67	2.58	2.58	0.52	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	309.26	10.71	2.38	1.19	3.57	8.33
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	382.04	9.95	1.58	1.58	3.39	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	289.08	9.02	1.45	3.49	4.65	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	287.21	6.30	0.90	4.05	2.70	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	361.75	7.99	1.08	0.81	3.12	3.25
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	295.28	5.14	1.03	3.59	2.57	6.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	286.17	7.76	1.76	2.12	2.82	3.18
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	273.19	12.66	2.00	2.00	4.66	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	296.46	5.60	2.55	3.06	4.58	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	279.35	5.60	1.07	3.74	3.47	3.47
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	282.85	8.31	1.51	3.59	3.21	3.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	271.81	4.91	1.23	0.61	3.68	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	341.66	5.71	1.63	0.82	8.15	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	283.63	7.71	1.25	2.29	2.71	4.16
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	276.06	8.69	0.28	3.36	4.20	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	295.71	9.27	2.06	3.09	7.21	8.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	264.76	8.71	0.58	2.03	2.03	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	282.49	4.19	1.79	2.09	4.48	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	262.24	8.85	3.32	1.66	4.43	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	308.59	7.78	1.41	1.41	3.89	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	284.70	4.06	1.11	2.21	2.58	4.43
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	285.52	10.36	1.15	1.15	4.61	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	303.55	8.44	1.15	2.69	2.30	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	296.09	5.10	1.13	3.96	3.40	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	313.42	10.67	2.46	0.82	3.28	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	282.43	9.49	0.90	1.81	4.07	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	335.37	8.62	2.15	2.87	5.75	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	340.59	7.47	1.49	2.99	2.24	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	300.62	9.29	1.49	2.60	4.46	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	325.64	9.05	0.43	1.29	2.15	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	267.16	8.56	0.86	2.57	3.43	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	310.85	10.99	2.33	3.66	3.33	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	339.66	4.83	2.41	3.02	4.22	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	320.66	11.38	2.13	2.13	3.55	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	304.53	9.62	2.06	1.37	5.84	4.47
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	341.37	7.51	1.07	2.68	3.76	4.83
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	276.08	11.45	3.37	1.35	6.73	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	307.07	10.00	0.00	2.22	4.07	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	327.95	9.30	0.00	2.33	4.65	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	306.75	10.58	1.06	4.23	5.29	6.35
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	308.52	6.00	3.20	2.40	2.40	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	301.65	5.09	1.45	5.81	2.18	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	347.23	9.96	4.60	3.83	4.60	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	310.27	12.33	1.48	1.97	2.96	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	296.39	6.59	0.00	6.59	4.70	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	314.77	5.03	3.02	2.51	3.02	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	296.51	8.56	1.80	3.15	3.15	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	251.28	8.61	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	281.01	9.35	3.12	0.45	6.68	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	287.40	11.34	0.39	3.52	5.87	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	316.67	3.30	1.32	3.30	3.30	3.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	312.91	10.38	4.15	6.23	7.26	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	280.92	4.81	0.88	1.31	3.94	5.25
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	323.72	5.03	0.56	1.12	3.35	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	257.92	7.95	1.77	2.65	5.74	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	326.70	10.41	0.77	3.09	6.56	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	308.88	3.04	0.00	2.03	3.04	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	260.98	7.21	1.92	3.84	4.81	4.81
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	273.11	7.16	1.59	3.98	3.18	3.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	276.47	5.47	1.82	3.04	2.43	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	316.11	8.99	2.77	3.46	4.84	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	303.99	7.22	0.76	1.90	2.66	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	317.60	5.68	0.52	4.65	4.65	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	384.56	6.65	1.21	0.60	4.23	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	287.11	7.61	1.90	2.22	5.39	3.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	321.99	5.86	1.60	4.80	1.60	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	345.95	11.49	1.72	4.60	7.47	5.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	283.34	5.14	1.54	3.09	4.63	6.17
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	335.29	7.07	0.71	5.66	2.83	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	330.28	10.78	0.57	1.70	5.11	3.97
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	297.46	8.32	3.74	3.74	4.16	2.91
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	364.90	12.53	1.57	3.13	2.35	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	349.90	9.60	2.09	3.76	4.18	3.76
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	295.04	7.90	1.86	2.79	6.04	5.58
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	362.62	6.69	1.34	4.01	2.01	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	335.22	6.42	1.07	1.07	7.48	3.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	313.58	6.87	1.62	2.83	3.64	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	308.37	6.42	1.84	2.75	5.51	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	336.08	3.56	1.78	2.67	5.33	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	329.95	6.27	2.28	4.56	1.71	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	302.93	4.60	1.53	3.83	3.07	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	366.61	11.49	2.19	3.83	5.47	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	289.10	9.80	0.89	2.67	6.24	4.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	383.43	11.44	0.00	2.60	4.42	3.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	435.00	5.97	1.99	2.65	5.97	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	247.35	10.39	0.00	0.00	8.31	4.16
Macrophage - monocyte derived, donor1	11232-116C8	51.74	7.98	0.00	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	28.63	9.54	0.18	0.00	1.10	0.00
Macrophage - monocyte derived, donor3	11389-118C3	41.16	8.39	0.39	0.26	0.39	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	131.16	11.68	2.66	3.19	2.12	1.06
Mallassez-derived cells, donor2	11929-125I3	74.63	8.56	2.54	1.90	1.43	0.48
Mallassez-derived cells, donor3	11930-125I4	102.85	10.15	3.06	3.47	1.53	0.83
Mammary Epithelial Cell, donor1	11273-116H4	101.04	7.27	2.99	1.49	0.80	0.90
Mammary Epithelial Cell, donor2	11350-117G9	122.48	10.42	2.03	2.03	2.90	1.45
Mammary Epithelial Cell, donor3	11422-118F9	167.37	8.23	2.49	0.75	2.99	1.25
Mast cell - stimulated, donor1	11487-119E2	65.76	14.91	0.68	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	97.76	8.54	0.54	0.22	0.87	0.11
Mast cell, donor2	11565-120D8	139.08	7.13	0.00	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	133.05	6.30	0.00	0.00	0.23	0.23
Mast cell, donor4	11567-120E1	146.09	8.86	0.18	0.00	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	55.89	7.76	0.22	0.00	0.67	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	95.72	4.67	0.00	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	92.58	8.83	0.11	0.00	0.46	0.23
Mast cell, expanded, donor8	11941-126A6	97.74	5.52	0.33	0.17	1.17	0.17
Melanocyte - dark, donor1	11502-119F8	132.83	6.77	0.80	0.20	0.60	0.00
Melanocyte - dark, donor2	11582-120F7	149.16	7.96	0.35	2.08	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	95.26	7.24	0.87	1.01	0.65	0.94
Melanocyte - light, donor1	11274-116H5	63.94	6.35	0.94	0.00	0.24	0.71
Melanocyte - light, donor2	11351-117H1	70.29	9.55	0.00	2.05	1.36	1.36
Melanocyte - light, donor3	11423-118G1	76.32	2.60	1.73	2.60	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	129.12	7.91	1.04	1.67	1.56	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	100.58	9.41	0.81	1.88	2.15	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	79.29	6.43	1.87	1.61	0.80	0.27
Meningeal Cells, donor1	11493-119E8	145.15	12.28	1.12	1.49	0.87	1.61
Meningeal Cells, donor2	11573-120E7	176.50	9.24	2.20	2.20	1.32	0.00
Meningeal Cells, donor3	11654-122E7	130.16	9.78	0.73	1.14	1.06	1.06
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	138.59	14.26	2.57	1.43	0.86	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	82.02	4.13	2.92	3.52	1.21	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	374.54	11.83	1.31	3.94	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	196.22	15.70	9.16	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	136.35	11.48	2.15	6.46	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	77.08	6.14	1.69	1.69	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	67.35	4.02	2.51	2.51	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	170.53	9.01	3.08	3.08	1.32	2.64
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	125.66	8.77	6.58	4.38	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	162.86	11.87	4.09	6.34	1.43	2.25
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	123.13	9.14	3.05	1.66	0.69	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	140.51	7.43	0.37	1.49	1.49	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	117.50	5.53	1.45	2.24	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	152.52	4.75	2.67	2.37	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	135.46	2.34	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	211.97	9.61	2.56	5.76	0.64	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	148.16	9.92	3.19	2.84	1.06	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	135.10	4.38	1.88	1.56	1.56	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	165.46	11.61	3.63	7.98	4.35	1.45
Mesothelial Cells, donor1	11247-116E5	63.91	7.69	2.12	0.80	1.59	0.80
Mesothelial Cells, donor2	12156-128G5	70.07	8.51	2.50	0.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	60.92	8.24	1.30	0.72	0.43	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	5.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	42.11	9.36	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	34.16	7.36	0.59	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	47.11	4.03	0.62	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	39.00	9.54	0.41	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	50.80	5.76	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.02	4.65	0.47	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	42.07	9.55	0.41	0.00	0.61	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	31.28	5.54	0.79	0.79	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	42.48	10.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	52.43	11.40	0.38	0.38	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	56.45	10.82	0.00	0.00	0.21	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	15.65	1.84	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.10	8.05	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	47.17	6.77	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.48	4.99	0.00	0.48	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	3.87	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	38.91	7.60	0.23	0.23	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	29.45	8.41	0.21	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.17	5.71	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	32.61	6.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.67	5.33	0.00	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	27.38	6.35	0.22	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	1.01	0.51	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	21.20	4.89	0.00	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	26.17	4.12	0.00	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	40.85	11.05	0.00	0.00	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.81	7.20	0.00	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	34.04	9.51	0.50	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	28.46	5.26	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	3.31	0.00	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	2.56	0.00	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	29.25	7.44	0.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	2.09	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	32.48	8.55	0.00	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.94	4.38	0.00	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.14	3.20	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	43.49	8.42	0.00	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	15.38	2.49	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	2.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	21.12	4.22	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	18.78	5.84	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	4.62	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	2.85	0.00	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	25.15	3.73	0.00	0.00	0.41	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	38.35	8.03	0.00	0.26	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.87	5.15	0.00	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.55	2.94	0.00	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	27.24	9.58	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.72	5.93	0.00	0.14	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.72	5.41	0.00	0.32	1.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.77	6.63	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.13	3.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	32.67	8.52	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	37.61	5.65	0.00	0.25	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	2.61	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	23.52	5.29	0.00	0.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	38.92	11.53	0.58	0.00	0.86	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	30.91	6.18	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	30.37	2.98	0.60	0.30	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	90.41	15.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	53.47	3.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	76.56	9.20	0.33	0.00	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	41.03	10.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	58.32	6.13	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	57.74	9.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	80.74	6.38	0.75	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.07	6.66	0.53	0.00	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	48.97	5.66	0.45	0.00	0.57	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	53.78	8.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	63.02	9.53	0.00	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	45.11	7.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	75.89	8.55	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	65.69	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	73.73	7.07	0.00	0.00	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	46.80	11.38	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	93.97	13.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	107.45	10.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	98.80	5.67	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	49.84	7.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	194.15	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	192.48	9.79	0.00	0.00	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	80.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	75.62	7.11	1.29	4.52	2.59	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	65.85	10.45	2.61	3.66	2.61	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.69	4.00	4.00	3.34	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.94	1.67	2.09	2.09	0.42	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	35.37	2.85	1.71	1.52	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	3.19	1.60	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	0.68	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	29.40	3.68	1.84	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	26.37	2.09	3.35	1.67	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.78	3.02	4.18	2.56	0.46	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	32.43	3.24	1.62	2.16	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	34.69	3.99	2.52	2.52	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	58.57	6.95	2.48	3.97	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.38	1.89	2.17	1.35	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	37.63	3.63	3.40	3.17	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.03	1.47	1.63	0.98	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	52.12	5.10	1.82	1.28	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	38.72	2.65	4.24	1.59	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	30.02	2.40	2.40	2.40	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	33.47	1.97	1.64	1.31	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.74	1.63	1.95	2.28	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.51	2.65	1.76	0.18	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	41.49	1.41	3.52	2.11	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	30.34	1.38	4.14	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	54.31	2.25	3.21	2.57	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	40.35	3.79	0.69	0.69	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	5.06	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	38.54	0.67	1.11	1.56	0.67	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	29.64	0.42	4.23	3.39	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	25.40	1.66	0.95	0.71	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	66.96	3.00	7.73	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	36.99	2.00	4.33	3.33	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	27.95	1.80	1.35	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.57	0.79	1.98	2.78	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	43.65	0.93	1.86	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	50.70	2.65	4.54	1.89	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	1.63	3.26	4.89	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	2.18	2.61	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.47	1.36	1.81	1.81	0.00	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	45.86	0.88	1.76	3.53	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	55.18	1.33	0.66	1.33	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	54.56	1.49	3.97	1.98	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	17.61	0.38	4.21	3.06	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	78.94	4.23	2.72	2.72	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.51	3.32	1.77	2.43	1.11	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	35.24	1.36	2.03	2.03	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	55.48	1.83	1.83	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.51	0.63	3.78	1.57	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.63	1.82	1.51	1.21	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	42.72	0.00	0.79	2.37	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	38.54	1.13	1.13	4.53	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	94.17	4.35	1.74	3.60	1.99	1.24
Myoblast, donor2	11322-117D8	89.18	8.82	3.45	4.22	0.58	0.38
Myoblast, donor3	11398-118D3	70.80	7.06	1.51	1.35	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	118.21	3.94	0.15	0.44	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	276.15	8.00	0.00	0.00	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	268.08	11.76	0.00	0.00	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	266.88	10.12	0.55	0.18	0.92	0.00
Neural stem cells, donor1	11275-116H6	84.93	9.07	0.73	0.36	0.36	0.36
Neural stem cells, donor2	11352-117H2	48.14	7.70	1.93	0.00	0.00	1.93
Neurons, donor1	11494-119E9	96.72	10.24	1.14	2.28	0.00	3.41
Neurons, donor2	11574-120E8	87.62	5.72	0.22	1.10	0.66	0.88
Neurons, donor3	11655-122E8	94.55	14.80	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	91.87	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	63.78	2.90	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	121.56	3.05	0.00	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	135.36	6.77	1.19	0.83	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	108.10	9.77	1.63	2.60	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	103.49	11.63	1.20	2.41	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	64.56	5.51	2.48	2.34	0.55	0.14
Olfactory epithelial cells, donor2	11934-125I8	73.53	4.92	1.45	1.88	0.87	0.72
Olfactory epithelial cells, donor3	11935-125I9	78.89	5.33	1.02	1.25	0.79	0.91
Olfactory epithelial cells, donor4	11936-126A1	81.03	3.41	1.36	1.75	0.49	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	129.99	8.43	2.41	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	177.60	6.59	3.40	2.13	1.28	0.85
Osteoblast - differentiated, donor2	11353-117H3	114.31	5.72	3.43	1.14	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	163.87	4.34	3.10	0.62	1.24	0.00
Osteoblast, donor1	11277-116H8	291.59	15.05	0.78	3.13	1.56	2.35
Osteoblast, donor2	11354-117H4	113.78	9.13	0.00	2.81	2.81	0.70
Osteoblast, donor3	11426-118G4	182.00	13.86	3.20	5.33	1.42	0.89
Pancreatic stromal cells, donor1	11249-116E7	112.54	8.17	1.68	2.27	0.67	0.34
Pericytes, donor1	11491-119E6	189.60	11.24	1.34	1.78	0.45	0.89
Pericytes, donor2	11571-120E5	159.14	11.77	1.58	2.49	0.68	1.13
Pericytes, donor3	11652-122E5	175.37	8.14	4.27	5.70	1.02	1.22
Perineurial Cells, donor1	11499-119F5	157.55	7.57	1.58	2.37	0.11	0.57
Perineurial Cells, donor2	11579-120F4	167.37	9.39	0.83	0.64	1.01	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	243.20	7.97	0.00	0.00	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	193.93	8.82	0.00	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	230.36	8.41	0.39	0.13	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	231.75	9.09	1.91	0.24	2.63	1.91
Placental Epithelial Cells, donor2	11355-117H5	170.77	4.44	3.33	2.22	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	248.75	11.19	0.98	1.57	0.39	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	59.81	5.70	1.27	0.95	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	80.29	6.00	0.19	2.25	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	59.26	6.13	0.78	1.44	0.78	0.13
Preadipocyte - breast, donor2	11328-117E5	84.66	10.81	2.70	2.25	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	71.07	6.82	1.28	1.49	1.28	0.11
Preadipocyte - omental, donor2	11329-117E6	53.25	3.93	0.87	2.18	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	68.04	8.02	1.43	4.73	1.29	0.72
Preadipocyte - perirenal, donor1	11469-119C2	102.36	6.89	7.87	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	140.66	11.36	6.14	4.30	3.69	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	148.57	9.74	2.12	2.48	1.95	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	149.68	12.60	3.07	6.13	1.02	0.51
Preadipocyte - visceral, donor1	11280-116I2	125.28	8.76	4.84	3.17	0.84	0.65
Preadipocyte - visceral, donor2	11357-117H7	125.17	8.74	3.22	2.30	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	131.87	10.03	3.97	5.02	0.42	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	118.57	1.06	0.91	0.75	0.91	1.21
Prostate Epithelial Cells, donor2	11331-117E8	76.37	5.01	2.30	3.79	1.90	0.81
Prostate Epithelial Cells, donor3	11404-118D9	84.63	1.59	1.65	0.55	0.37	0.12
Prostate Stromal Cells, donor1	11254-116F3	128.02	6.95	1.14	2.39	1.03	1.14
Prostate Stromal Cells, donor2	11332-117E9	166.75	12.19	3.23	3.94	0.72	1.79
Prostate Stromal Cells, donor3	11405-118E1	115.12	7.20	1.56	2.29	0.83	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	178.48	10.58	2.92	1.09	1.09	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	124.00	8.04	1.11	1.39	0.42	0.07
Renal Epithelial Cells, donor1	11517-119H5	232.31	18.77	1.01	1.52	1.52	1.52
Renal Epithelial Cells, donor2	11597-120H4	144.40	14.94	0.71	2.13	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	134.02	8.36	0.95	1.80	0.42	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	115.74	6.81	0.68	1.36	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	122.37	6.87	2.29	2.96	0.67	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	91.47	6.88	1.78	2.00	1.33	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	115.79	9.32	1.33	0.00	0.00	3.33
Renal Mesangial Cells, donor1	11518-119H6	164.19	13.65	1.98	1.10	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	112.23	11.91	0.63	0.63	1.25	1.88
Renal Mesangial Cells, donor3	11679-122H5	182.81	12.76	1.94	2.22	0.55	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	168.84	9.13	2.15	1.34	0.81	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	134.52	6.75	1.27	0.84	0.42	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	198.63	13.50	1.74	1.35	1.35	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	160.50	12.45	0.52	0.26	1.04	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	98.63	7.96	2.27	0.57	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	130.70	13.38	4.12	7.20	3.09	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	100.36	9.03	0.50	1.25	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	158.89	3.47	0.53	0.00	0.94	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	89.34	3.57	4.47	0.00	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	208.59	10.46	0.55	2.20	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	88.17	9.28	0.58	1.74	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	93.75	17.94	2.21	1.30	1.95	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	130.59	21.05	2.98	2.09	3.67	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	154.15	22.08	2.68	2.01	4.91	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	218.19	36.96	1.61	3.10	4.09	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	146.61	24.47	3.38	2.33	2.80	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	156.94	24.73	2.08	2.77	2.77	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	143.62	15.61	2.05	2.05	2.46	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	140.99	23.60	3.03	2.42	3.03	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	138.33	15.59	1.79	2.15	4.12	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	177.31	23.10	2.58	1.58	3.87	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	152.92	28.55	2.68	2.04	2.47	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	155.33	26.77	3.10	5.75	3.54	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	128.28	11.09	1.91	1.53	2.10	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	126.89	20.78	2.89	2.33	1.86	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	135.86	19.54	2.07	1.69	2.07	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	112.93	16.59	2.65	0.93	2.12	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	126.64	26.09	2.73	2.24	3.80	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	158.69	23.68	3.63	1.72	2.86	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	129.11	21.15	2.24	1.71	3.52	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	121.37	23.55	3.36	1.40	1.40	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	128.52	17.94	3.59	2.73	3.59	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	128.36	14.95	2.92	1.64	1.09	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	143.85	24.77	2.58	0.86	3.43	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	164.14	31.43	4.03	2.82	3.76	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	178.79	17.45	3.54	2.83	2.36	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	136.11	25.60	1.98	2.78	2.78	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	161.35	29.00	3.98	4.68	4.68	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	174.39	20.74	2.90	1.04	3.32	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	128.97	26.10	2.21	2.43	2.21	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	141.62	24.44	3.97	3.97	4.18	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	169.17	21.13	2.42	2.56	4.17	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	102.35	18.05	2.90	3.41	2.21	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	128.02	21.01	5.21	3.47	3.47	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	177.10	23.21	2.24	2.92	2.92	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	106.85	21.12	2.88	2.19	1.65	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	133.80	22.66	3.61	3.45	3.12	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	156.63	20.28	2.05	1.53	2.90	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	168.08	32.85	3.85	5.18	3.85	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	109.29	19.19	3.20	5.06	3.73	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	145.73	18.67	1.80	1.94	2.07	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	172.86	26.67	1.67	1.90	2.38	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	131.81	19.95	3.22	2.22	2.82	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	184.58	25.05	1.88	1.70	2.73	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	207.52	28.65	1.75	2.10	1.40	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	119.07	13.90	2.12	3.02	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	199.61	23.25	1.71	1.22	3.67	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	155.89	17.03	1.89	3.35	1.46	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	173.40	20.08	3.65	3.65	4.26	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	216.71	22.00	1.21	2.41	3.01	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	173.71	19.23	1.58	1.58	2.94	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	160.85	19.17	2.70	2.40	2.70	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	147.71	18.30	1.53	1.53	2.01	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	153.25	19.42	1.71	2.56	3.63	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	109.98	10.82	2.40	3.00	0.60	0.60
Schwann Cells, donor1	11498-119F4	253.71	15.61	4.51	2.44	0.75	0.94
Schwann Cells, donor2	11578-120F3	146.30	10.21	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	92.67	9.86	2.85	0.66	0.88	1.53
Sebocyte, donor1	11220-116B5	173.10	8.76	4.38	2.74	2.74	0.55
Sebocyte, donor2	11301-117B5	127.76	6.89	1.84	2.30	1.38	1.84
Sebocyte, donor3	11378-118B1	158.09	4.95	2.47	2.89	1.03	1.24
Sertoli Cells, donor1	11255-116F4	125.90	11.60	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	186.41	8.47	0.00	8.47	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	153.87	11.53	1.23	1.76	0.79	0.26
Skeletal Muscle Cells, donor2	11358-117H8	148.91	9.40	1.45	2.17	2.89	2.89
Skeletal Muscle Cells, donor3	11430-118G8	237.43	15.05	2.51	5.02	3.34	0.84
Skeletal Muscle Cells, donor4	11451-119A2	150.50	12.10	2.98	3.14	1.10	1.41
Skeletal Muscle Cells, donor5	11455-119A6	137.05	7.43	2.53	4.46	0.74	1.49
Skeletal Muscle Cells, donor6	11459-119B1	156.98	10.62	4.77	3.54	0.62	2.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	179.94	9.70	2.52	2.39	0.76	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	134.41	8.70	3.14	2.71	0.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	150.40	8.53	3.67	2.98	1.59	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	146.77	9.10	1.35	2.70	0.84	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	175.87	12.30	3.62	3.62	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	133.06	13.48	3.85	3.85	0.83	0.55
Skin - palm, donor1	10286-104F7	32.23	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	95.00	2.16	0.86	3.17	0.72	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	41.71	4.09	3.27	10.63	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	103.47	2.47	2.47	1.69	1.04	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	87.71	5.70	1.39	1.53	0.56	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	75.53	4.50	3.38	1.97	0.42	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	98.75	5.07	6.98	3.38	1.69	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	49.24	2.77	1.95	0.67	0.75	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	215.08	10.49	5.55	5.86	3.39	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	79.15	6.00	2.00	4.22	1.33	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	135.79	6.47	4.11	1.18	0.59	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	103.87	7.07	1.99	1.99	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	164.60	7.48	5.12	6.30	0.79	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	156.06	5.41	5.41	1.55	3.09	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	188.14	5.00	1.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	151.84	11.71	3.73	4.39	1.06	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	126.79	9.09	4.88	5.32	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	159.27	10.11	11.14	13.70	2.69	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	103.54	7.16	1.63	1.95	1.95	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	77.08	12.11	1.77	2.36	0.59	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	86.98	6.98	3.56	3.56	1.14	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	147.38	13.50	3.58	3.58	0.98	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	69.11	4.87	1.52	1.22	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	189.17	12.12	3.28	2.02	0.76	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	6.12	12.24	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	132.08	8.11	2.86	2.38	1.91	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	115.03	7.67	2.06	1.62	0.59	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	116.87	5.38	2.15	3.66	1.08	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	124.90	8.50	2.62	2.31	1.05	1.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	166.74	10.21	5.41	5.10	1.55	2.32
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	126.11	11.86	8.62	11.86	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	111.77	5.68	3.59	2.39	0.90	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	179.92	16.39	2.39	3.41	1.02	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	177.87	5.73	1.33	0.79	0.47	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	72.46	7.25	2.72	3.32	1.21	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	103.08	8.87	2.96	3.64	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	184.16	9.66	7.25	4.23	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	170.08	11.13	3.71	4.77	2.65	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	101.33	6.39	1.86	1.86	1.20	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	137.12	9.64	3.76	5.38	1.75	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	106.54	7.61	2.54	1.52	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	129.36	7.99	3.77	3.92	0.90	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	142.53	6.75	4.50	4.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	52.98	3.88	2.58	7.75	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	148.82	11.63	6.05	3.72	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	158.03	7.07	3.03	3.53	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	109.37	13.16	6.58	7.21	0.94	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	90.86	8.26	3.24	3.54	0.88	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	135.79	10.16	3.25	1.75	1.00	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	97.64	7.94	3.27	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	155.00	10.79	4.32	2.73	1.73	2.16
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	147.87	15.30	1.02	4.84	2.80	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	153.44	10.91	5.08	4.32	0.94	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	119.48	8.80	1.68	1.82	0.56	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	179.56	8.13	2.35	1.42	0.34	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	153.81	8.57	6.67	4.29	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	136.28	12.23	4.16	3.18	1.96	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	97.66	6.63	3.76	4.20	0.44	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	119.08	8.78	1.17	2.05	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	92.90	3.11	0.78	0.19	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	52.89	5.29	2.12	1.59	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	103.03	2.98	0.74	1.86	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	76.54	2.87	3.23	6.83	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	53.09	3.69	3.69	2.84	1.14	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	115.01	3.54	0.00	2.76	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	68.31	3.56	1.78	2.29	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	73.87	3.59	2.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	86.95	4.18	1.25	1.67	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	114.13	4.58	0.46	0.92	0.46	0.92
Synoviocyte, donor1	11291-117A4	107.39	5.22	1.18	1.18	0.34	0.50
Synoviocyte, donor2	11368-117I9	144.49	7.88	0.84	1.01	0.50	0.34
Synoviocyte, donor3	11440-118H9	153.26	5.81	0.67	0.89	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	182.60	10.36	2.50	4.29	3.22	5.00
Trabecular Meshwork Cells, donor2	11612-122A1	146.67	19.82	5.95	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	159.07	18.29	1.85	3.70	1.85	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	149.53	6.02	2.37	1.58	0.65	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	155.78	8.12	3.87	1.93	1.93	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	129.99	10.88	2.86	2.86	3.44	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	163.13	2.83	0.12	0.25	0.62	0.12
Urethra, donor2	10319-105A4	59.35	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	130.44	11.16	4.25	3.19	1.59	1.33
Urothelial Cells, donor2	11600-120H7	119.77	8.01	3.61	2.80	1.60	0.40
Urothelial Cells, donor3	11681-122H7	149.44	8.94	2.06	1.83	0.46	0.23
Urothelial cells, donor0	11216-116B1	137.97	9.36	2.23	1.56	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	197.53	6.23	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	207.29	11.44	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	140.33	6.85	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	201.44	3.10	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	252.75	4.07	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	167.64	4.16	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	164.28	3.67	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	170.71	2.74	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	86.85	9.38	1.85	1.36	1.36	0.86
Wilms' tumor cell line:HFWT	10597-108E3	44.00	2.64	4.40	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	200.27	12.29	2.51	2.23	1.68	1.40
achilles tendon, donor2	10292-104G4	20.67	4.13	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	118.81	8.41	0.76	1.27	2.04	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	187.36	11.84	3.48	1.86	2.09	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	179.72	9.02	0.47	0.59	0.47	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	124.08	7.07	3.27	0.00	3.81	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	176.80	22.21	9.28	6.18	3.65	3.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	145.29	10.15	1.27	0.21	1.06	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	148.90	5.17	2.18	1.63	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	311.53	19.83	12.78	8.81	3.97	4.41
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	90.25	5.72	5.31	2.45	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	270.26	17.47	8.54	2.72	2.72	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	87.03	7.54	1.66	1.10	2.39	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	117.02	15.60	0.00	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	151.98	16.27	2.32	1.39	1.39	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	219.81	26.67	2.33	2.59	3.88	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	210.71	30.39	1.75	2.05	3.80	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	85.98	7.90	1.39	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	66.21	6.99	0.41	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	58.01	6.75	6.14	0.00	3.99	2.76
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	107.53	24.75	2.13	1.28	1.28	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	132.54	26.69	2.43	0.91	2.73	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	134.80	26.72	3.37	0.72	1.68	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	139.21	7.57	2.90	0.22	3.12	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	81.05	8.34	0.00	0.00	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	79.90	13.01	3.72	1.86	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	89.27	20.72	1.88	2.64	3.01	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	48.85	8.72	0.87	0.00	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	3.75	1.87	1.87	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	97.50	6.59	3.53	1.41	0.24	0.71
adipose tissue, adult, pool1	10010-101C1	144.57	3.10	0.16	0.00	0.47	0.00
adipose, donor1	10184-103D4	83.27	15.25	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	55.56	4.87	1.22	0.00	1.62	0.81
adipose, donor3	10186-103D6	61.54	9.26	1.36	0.27	1.91	1.63
adipose, donor4	10187-103D7	52.87	6.93	3.47	1.73	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	55.08	6.31	4.26	0.16	0.63	1.10
adrenal gland, adult, pool1	10081-102A9	90.94	0.00	0.00	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	75.51	4.80	2.00	0.67	0.80	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	137.20	6.43	3.57	0.71	1.43	1.43
amniotic membrane cells, donor1	12235-129G3	105.03	1.85	1.39	0.70	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	150.79	3.72	0.00	0.00	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	160.85	2.95	0.00	0.29	0.59	0.00
amygdala - adult, donor10196	10167-103B5	33.20	3.56	0.00	1.19	1.19	1.19
amygdala, adult, donor10252	10151-102I7	54.34	2.43	0.81	0.81	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	36.47	0.97	0.65	2.90	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	176.61	4.07	2.42	1.15	0.38	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	228.35	10.15	3.75	3.09	1.99	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	149.31	4.34	3.67	0.33	0.33	0.00
aorta, adult, pool1	10052-101G7	110.62	3.53	0.78	0.20	0.20	0.00
appendix, adult	10189-103D9	162.23	8.15	1.55	0.00	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	98.37	5.85	2.75	0.69	1.03	0.00
artery, adult	10190-103E1	285.32	4.08	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	87.35	10.58	1.74	0.58	0.58	0.29
b cell line:RPMI1788	10427-106D4	124.02	9.81	1.78	0.30	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	66.31	7.49	1.94	1.66	0.83	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	216.23	5.06	1.39	0.50	1.09	2.48
bile duct carcinoma cell line:TFK-1	10496-107C1	120.68	2.51	0.00	0.00	0.33	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	219.22	10.63	3.36	0.00	1.68	1.68
bladder, adult, pool1	10011-101C2	145.47	3.37	0.43	0.22	0.11	0.00
blood, adult, pool1	10053-101G8	174.96	6.64	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	124.17	10.12	0.67	0.67	2.02	0.67
brain, adult, donor1	10084-102B3	71.75	2.05	2.05	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	49.89	1.89	0.22	0.78	0.56	0.22
brain, fetal, pool1	10085-102B4	88.16	5.34	0.00	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	118.27	1.98	0.33	1.98	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	120.95	4.87	3.12	1.50	0.87	1.00
breast, adult, donor1	10080-102A8	126.90	1.26	1.26	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	159.05	8.64	12.20	2.54	1.65	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	148.74	15.15	8.04	1.24	1.55	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	86.56	9.44	0.69	0.23	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	90.30	6.05	3.15	1.94	0.97	1.45
carcinoid cell line:NCI-H1770	10703-109H1	40.43	2.82	4.23	5.17	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	42.11	1.09	0.66	0.22	0.22	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	126.76	15.21	5.39	1.27	0.63	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	143.20	6.39	1.33	2.13	0.00	1.33
caudate nucleus - adult, donor10196	10177-103C6	37.99	3.45	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	55.89	2.84	0.67	0.17	0.33	0.00
caudate nucleus, adult, donor10258	10379-105H1	43.56	6.11	3.06	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	64.09	3.66	0.37	1.83	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	32.05	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	85.19	2.14	0.21	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	81.75	3.10	1.03	0.69	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	118.73	1.66	1.66	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	53.45	3.28	1.26	0.25	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	61.39	0.73	1.46	0.00	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	109.56	6.90	8.20	5.03	1.29	1.58
cervical cancer cell line:ME-180	10553-107I4	108.54	2.82	0.50	0.00	0.17	0.66
cervix, adult, pool1	10013-101C4	188.67	3.46	0.00	0.00	0.10	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	112.86	7.52	2.09	1.81	2.51	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	1.31	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	94.08	5.97	1.24	0.50	0.87	0.12
choriocarcinoma cell line:SCH	10785-110H2	152.91	17.74	0.62	0.99	1.23	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	35.58	0.47	5.69	0.95	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	71.23	3.99	0.57	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	97.64	6.26	1.89	0.89	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	70.88	2.75	0.55	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	151.47	8.08	0.00	0.00	2.02	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	150.80	13.45	6.34	4.99	0.96	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	84.05	18.16	9.08	3.17	1.06	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	113.25	17.98	6.16	6.42	1.54	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	116.34	20.80	8.71	5.81	2.66	2.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	106.28	18.53	3.66	2.24	1.83	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	108.07	17.37	4.42	1.77	1.47	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	151.94	30.75	2.35	1.82	1.04	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	120.23	13.03	2.29	0.46	0.46	1.37
clear cell carcinoma cell line:TEN	10636-108I6	165.87	5.21	1.91	0.17	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	127.40	3.84	0.73	0.55	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	204.48	11.78	2.28	1.52	1.52	0.76
colon, adult, donor1	10082-102B1	146.37	5.95	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	166.50	4.82	0.35	0.12	0.71	0.12
colon, fetal, donor1	10070-101I7	135.96	1.85	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	59.59	0.00	13.75	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	400.59	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	116.86	4.67	0.85	0.00	0.42	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	130.40	6.49	1.21	0.30	1.66	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	130.58	7.76	1.41	0.42	1.27	1.27
corpus callosum, adult, pool1	10042-101F6	128.03	4.20	0.11	0.88	1.00	0.33
cruciate ligament, donor2	10295-104G7	58.35	1.62	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	158.10	2.41	0.00	0.00	1.61	0.00
diencephalon, adult	10193-103E4	45.36	2.40	1.44	1.20	0.96	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	178.64	12.86	1.15	1.38	1.84	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	100.52	5.64	1.54	0.51	1.80	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	72.22	3.61	1.69	1.69	0.48	0.96
ductus deferens, adult	10196-103E7	139.04	5.98	2.99	1.00	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	151.22	2.88	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	135.36	3.68	0.74	0.00	0.74	2.21
dura mater, adult, donor1	10041-101F5	141.14	8.09	0.33	0.17	0.58	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	78.17	3.55	0.67	3.33	1.55	3.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	113.06	3.87	1.43	2.87	1.43	2.58
embryonic pancreas cell line:1B2C6	10604-108F1	77.69	4.93	7.40	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	101.11	6.96	11.81	2.42	1.21	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	88.61	5.56	8.34	2.78	0.93	0.93
embryonic pancreas cell line:2C6	10603-108E9	72.24	3.94	3.94	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	35.20	5.36	5.03	4.02	1.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	94.06	10.33	1.45	0.18	0.91	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	130.42	6.11	1.77	0.48	1.13	0.00
epidermoid carcinoma cell line:A431	10426-106D3	95.60	6.11	1.33	0.89	0.44	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	177.63	12.10	3.41	1.54	3.19	2.42
epididymis, adult	10197-103E8	141.49	6.49	0.42	0.21	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	55.53	3.90	0.53	0.53	0.53	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	112.86	5.90	1.97	1.97	1.97	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	144.15	9.04	2.36	1.18	1.57	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	141.72	9.15	1.48	0.49	2.07	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	165.92	9.63	3.47	1.12	2.58	2.02
esophagus, adult, pool1	10015-101C6	155.55	3.29	0.64	0.32	0.42	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	97.31	8.89	0.50	0.50	0.63	0.13
eye - muscle inferior rectus, donor1	10272-104E2	38.63	2.41	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	1.49	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	33.25	3.44	0.00	0.00	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	30.61	2.91	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	156.61	3.05	0.51	0.25	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	81.29	7.95	2.56	1.67	1.15	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	112.77	4.51	4.04	3.32	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	44.85	1.97	0.84	0.47	0.66	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	100.58	11.11	0.60	1.20	0.90	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	70.41	5.67	5.39	1.55	0.64	0.55
gall bladder, adult	10198-103E9	183.25	4.35	1.69	0.48	0.97	0.97
gamma delta positive T cells, donor1	11937-126A2	352.18	9.13	0.54	0.54	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	262.94	8.96	0.00	0.00	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	133.28	11.62	3.17	2.75	2.53	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	212.18	7.16	4.64	2.13	1.55	0.77
gastric cancer cell line:AZ521	10549-107H9	110.67	7.38	1.31	0.66	0.00	0.33
gastric cancer cell line:GSS	10560-108A2	86.03	6.41	6.41	0.92	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	50.49	1.37	0.46	0.23	0.46	0.46
giant cell carcinoma cell line:LU65	10487-107B1	54.85	4.02	1.15	1.15	0.46	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	162.07	20.85	9.10	5.46	1.96	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	71.58	2.99	1.50	0.75	1.25	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	53.83	4.33	0.42	0.95	1.06	1.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	39.88	2.39	0.70	0.28	0.84	0.70
glioblastoma cell line:T98G	10485-107A8	128.58	12.69	2.98	1.99	1.21	1.21
glioma cell line:GI-1	10413-106B8	93.72	4.39	1.76	1.17	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	35.72	0.73	0.73	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	95.69	1.95	0.98	0.49	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	69.83	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	65.55	1.07	0.00	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	90.54	9.79	4.89	2.45	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	240.42	10.93	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	297.92	15.68	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	48.00	4.16	1.28	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	61.52	11.48	2.75	2.75	1.38	2.30
hIPS +CCl2, biol_rep2	14384-156C1	52.13	5.03	2.29	3.20	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	65.70	7.73	2.58	1.93	2.58	3.86
hIPS, biol_rep1	14380-156B6	7.19	1.44	0.00	4.31	1.44	1.44
hIPS, biol_rep2	14381-156B7	72.02	5.49	2.74	3.43	4.80	6.17
hIPS, biol_rep3	14382-156B8	45.24	1.10	0.00	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	88.79	6.90	3.74	1.44	0.29	0.57
heart - mitral valve, adult	10205-103F7	125.27	5.08	2.09	0.90	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	127.08	3.40	1.57	0.00	1.05	0.78
heart - tricuspid valve, adult	10207-103F9	119.90	2.50	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	116.11	7.96	1.63	0.41	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	154.15	5.96	0.00	0.00	1.70	0.85
heart, adult, pool1	10016-101C7	123.50	3.68	1.38	0.46	1.15	0.46
heart, fetal, pool1	10046-101G1	227.33	7.29	0.62	0.21	1.54	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	58.31	6.17	3.09	1.85	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	115.35	1.19	0.00	2.38	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	171.60	5.86	1.55	1.44	0.66	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	186.92	6.80	1.21	1.46	1.94	2.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	197.76	7.17	1.72	1.72	2.02	1.31
hepatoma cell line:Li-7	10484-107A7	101.10	10.01	0.11	0.44	1.45	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	124.62	11.76	2.71	1.31	2.01	1.61
hippocampus - adult, donor10196	10169-103B7	34.07	1.89	0.95	2.84	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	68.37	2.25	0.82	1.22	0.61	0.41
hippocampus, adult, donor10258	10374-105G5	29.88	1.00	1.00	1.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	29.26	0.35	0.70	2.82	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	177.61	9.16	2.44	1.83	3.05	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	131.36	13.16	6.09	2.16	2.16	2.95
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	154.37	9.14	2.54	0.76	2.03	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	97.55	11.84	3.95	0.00	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	104.32	20.40	3.10	3.61	0.52	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	152.98	18.22	1.14	1.14	1.14	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	94.30	11.09	0.00	0.58	1.46	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	98.02	11.20	1.29	0.65	1.51	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	95.93	10.01	1.67	0.83	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	128.82	14.21	0.95	0.47	1.42	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	119.09	13.50	1.13	1.61	1.29	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	117.15	12.12	0.67	0.67	3.37	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	125.97	9.86	1.88	1.10	1.56	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	123.81	8.84	2.46	1.47	4.91	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	178.04	13.09	0.87	0.87	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	106.15	15.85	2.48	2.48	1.34	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	83.29	9.59	2.18	2.18	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	82.96	13.49	1.50	1.00	1.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	83.83	11.68	0.38	0.38	0.94	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	75.94	9.09	0.45	1.36	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	82.07	7.20	0.63	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	77.24	9.31	0.33	0.65	1.63	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	75.48	11.32	0.58	1.45	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	72.34	6.88	0.90	0.60	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	131.54	11.27	3.88	3.14	1.85	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	113.83	10.27	3.14	1.71	2.85	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	174.35	14.70	6.94	5.31	4.08	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	85.20	15.49	1.76	1.76	0.35	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	80.45	6.97	2.22	2.22	1.58	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	117.11	13.92	1.51	2.42	1.82	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	76.02	9.31	1.03	0.52	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	58.45	10.63	1.33	0.66	0.00	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	94.40	7.44	0.26	0.77	1.80	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	83.85	12.53	0.26	0.26	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	87.84	9.09	0.00	0.76	0.76	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	95.44	9.75	0.67	2.35	2.35	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	120.99	11.83	4.59	2.90	2.66	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	140.38	8.47	2.23	5.35	2.23	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	120.00	5.85	6.83	7.32	4.39	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	85.57	12.84	1.83	0.61	0.92	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	162.66	42.29	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	139.66	21.18	1.65	1.32	0.33	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	85.38	9.30	1.64	2.19	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	104.95	8.32	1.81	0.72	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	95.02	11.39	0.00	1.07	1.07	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	76.38	7.16	1.19	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	113.62	13.68	0.54	0.95	1.22	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	92.40	7.54	0.27	0.27	1.89	3.23
immature langerhans cells, donor1	11904-125F5	83.54	10.65	0.00	0.00	0.00	0.48
immature langerhans cells, donor2	11905-125F6	147.34	19.80	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	49.78	2.74	1.14	0.66	0.38	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	92.02	6.18	4.55	3.90	1.30	0.65
kidney, adult, pool1	10017-101C8	113.34	5.71	0.60	0.30	0.70	0.80
kidney, fetal, pool1	10045-101F9	183.70	6.51	0.35	0.21	0.64	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	111.49	18.75	5.54	1.42	1.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	103.96	5.67	0.69	0.97	0.41	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	97.62	3.30	3.67	2.94	1.28	0.37
left atrium, adult, donor1	10079-102A7	139.48	4.90	5.45	3.81	2.72	1.09
left ventricle, adult, donor1	10078-102A6	130.96	1.01	0.51	0.51	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	70.59	3.56	10.12	6.84	1.09	1.09
leiomyoma cell line:10964C	10569-108B2	108.49	8.62	5.75	10.42	1.08	0.72
leiomyoma cell line:15242A	10570-108B3	84.78	6.52	1.63	4.89	2.72	1.09
leiomyoma cell line:15425	10571-108B4	97.85	8.01	5.34	4.13	1.21	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	6.35	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	38.69	6.27	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	129.39	18.18	9.68	7.91	2.24	0.83
liposarcoma cell line:KMLS-1	10782-110G8	133.72	4.37	2.03	5.15	0.94	0.31
liposarcoma cell line:SW 872	10726-110A6	91.01	8.29	4.26	5.24	1.34	0.37
liver, adult, pool1	10018-101C9	182.97	7.29	0.97	0.81	1.46	1.13
liver, fetal, pool1	10086-102B5	65.85	2.82	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	44.48	1.31	1.75	3.79	0.44	0.29
locus coeruleus, adult, donor10252	10165-103B3	64.22	2.95	1.11	1.29	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	45.42	3.39	1.13	1.41	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	69.82	2.52	0.00	1.26	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	112.79	6.92	3.60	0.69	0.97	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	49.64	2.07	2.76	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	96.23	9.23	7.38	2.24	1.19	0.66
lung, adult, pool1	10019-101D1	159.24	4.84	0.24	0.00	0.12	0.35
lung, fetal, donor1	10068-101I5	172.39	5.14	0.29	0.29	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	122.34	5.50	0.00	0.46	0.46	0.00
lymph node, adult, donor1	10077-102A5	262.72	9.47	0.00	0.47	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	95.56	7.89	2.85	0.44	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	120.29	11.32	3.32	0.30	1.36	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	137.62	2.55	0.00	0.00	1.70	0.85
mature adipocyte, donor1	12231-129F8	79.92	2.66	0.89	0.00	0.00	0.89
mature adipocyte, donor2	12232-129F9	95.46	0.62	1.25	0.21	0.83	0.00
mature adipocyte, donor3	12233-129G1	69.22	3.56	0.24	0.00	0.24	0.24
mature adipocyte, donor4	12234-129G2	76.07	2.90	0.53	0.00	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	78.15	5.48	5.48	0.48	0.71	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	2.26	0.00	3.38	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	50.39	2.21	0.74	1.29	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	24.14	1.59	0.64	2.22	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	29.43	0.85	0.00	1.28	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	30.21	2.03	0.34	1.35	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	50.30	2.55	1.27	0.85	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	1.93	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	33.74	1.08	0.36	1.79	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	53.87	2.60	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	84.68	2.17	0.77	1.39	0.15	0.31
medulla oblongata, adult, pool1	10038-101F2	76.16	3.75	1.06	1.22	0.41	0.33
medulla oblongata, newborn, donor10223	10361-105F1	86.45	2.78	0.35	0.69	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	196.61	14.17	5.54	10.85	0.89	1.55
medulloblastoma cell line:ONS-76	10759-110E3	85.47	7.34	8.07	5.75	2.32	1.35
melanoma cell line:COLO 679	10514-107E1	61.52	5.32	0.57	0.72	0.43	0.43
melanoma cell line:G-361	10465-106H6	56.19	10.04	2.71	2.71	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	148.70	10.13	9.59	4.52	0.90	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	81.95	7.05	1.76	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	95.65	12.96	8.04	10.89	1.04	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	184.12	9.97	5.06	4.14	1.38	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	158.88	13.09	2.54	2.54	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	147.83	10.35	1.24	4.14	0.41	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	131.34	11.10	2.25	1.55	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	152.32	8.67	2.70	2.31	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	56.22	2.78	0.69	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	155.16	11.33	3.26	3.09	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	124.22	9.43	2.53	2.30	0.81	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	133.70	11.41	2.92	2.92	1.06	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	126.26	11.34	1.76	2.03	1.62	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	99.73	9.67	1.00	1.71	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	73.78	5.60	0.99	0.99	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	108.62	8.58	2.49	2.08	0.69	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	78.89	8.73	3.49	4.89	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	119.23	7.96	2.45	3.67	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	63.62	5.39	2.52	1.08	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	105.21	10.86	2.17	1.86	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	51.53	4.56	2.74	2.28	0.68	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	176.21	7.97	2.94	3.36	1.26	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	113.27	14.35	2.54	1.20	0.60	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	131.03	10.77	2.28	0.96	1.05	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	78.79	4.42	1.10	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	58.66	6.87	1.43	2.86	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	111.57	13.89	1.26	1.68	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	125.58	4.57	2.74	3.20	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	86.20	8.19	2.56	4.09	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	82.19	6.02	1.05	2.36	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	93.66	5.24	1.54	2.46	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	86.85	4.24	2.82	2.12	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	95.11	5.42	2.37	3.72	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	80.95	7.07	1.96	2.36	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	84.34	4.63	1.85	1.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	120.27	6.06	2.88	2.88	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	89.46	6.02	3.57	2.45	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	89.65	6.73	3.12	3.36	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	61.60	5.13	1.47	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	85.26	4.36	2.35	0.00	1.01	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	83.51	7.37	2.87	2.46	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	75.17	2.58	1.29	2.58	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	120.31	8.20	5.47	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	160.11	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	96.14	6.82	1.30	3.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	88.75	4.36	2.91	4.36	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	115.15	6.93	1.07	4.80	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	94.86	9.00	1.64	1.64	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	96.79	5.83	1.17	2.72	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	79.75	6.30	2.10	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	111.27	1.99	0.00	1.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	81.04	14.30	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	90.72	7.12	3.56	4.15	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	119.41	4.87	4.87	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	100.07	5.70	2.53	2.53	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	100.37	2.41	2.41	2.07	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	107.46	6.45	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	107.78	7.98	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	120.54	3.44	3.44	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	113.68	3.26	5.30	1.22	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	153.33	4.77	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	130.87	1.77	4.13	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	95.38	3.12	3.12	1.87	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	105.60	0.00	5.35	6.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	98.16	3.55	2.37	3.55	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	123.26	2.57	0.00	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	119.78	3.44	0.69	5.51	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	114.30	4.95	1.48	2.97	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	91.96	3.36	0.00	2.24	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	106.22	5.72	4.45	2.54	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	76.16	6.04	0.00	0.40	1.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	113.39	4.36	0.00	0.00	4.36	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	111.50	5.07	0.00	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	84.36	6.07	0.61	0.61	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	85.86	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	87.31	2.47	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	73.42	2.38	0.60	0.60	0.79	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	72.04	2.60	1.30	2.27	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	84.55	3.06	2.04	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	22.44	1.55	0.00	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	64.49	10.87	5.67	1.89	0.47	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	63.48	4.40	1.16	0.93	0.70	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	128.21	12.82	4.27	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	94.53	4.01	1.23	1.13	1.44	1.44
mesothelioma cell line:Mero-25	10850-111F4	81.25	4.54	0.45	1.59	1.13	1.36
mesothelioma cell line:Mero-41	10851-111F5	111.97	8.80	1.71	3.42	1.47	0.00
mesothelioma cell line:Mero-48a	10852-111F6	172.94	9.96	6.20	3.32	1.55	0.89
mesothelioma cell line:Mero-82	10853-111F7	208.40	13.40	2.37	7.10	4.99	2.89
mesothelioma cell line:Mero-83	10854-111F8	142.99	6.30	3.40	6.98	2.55	3.57
mesothelioma cell line:Mero-84	10855-111F9	104.90	4.30	1.26	1.52	1.26	1.01
mesothelioma cell line:Mero-95	10856-111G1	159.42	6.21	5.18	7.45	2.69	2.69
mesothelioma cell line:NCI-H2052	10847-111F1	273.65	7.29	3.15	4.97	2.48	3.31
mesothelioma cell line:NCI-H226	10846-111E9	173.93	8.87	2.17	8.51	3.44	2.35
mesothelioma cell line:NCI-H2452	10848-111F2	120.43	7.86	3.25	4.10	1.20	0.34
mesothelioma cell line:NCI-H28	10845-111E8	80.67	2.54	0.00	0.51	1.53	0.76
mesothelioma cell line:No36	10857-111G2	112.54	4.89	0.33	0.65	1.96	0.33
mesothelioma cell line:ONE58	10858-111G3	81.83	6.23	1.63	2.98	1.08	1.35
migratory langerhans cells, donor1	11901-125F2	80.22	12.67	0.19	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	67.41	7.08	0.12	0.00	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	79.51	5.20	0.00	0.00	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	65.30	8.16	0.65	1.96	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	47.69	18.01	6.78	2.33	2.33	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	94.91	2.53	1.84	0.92	1.38	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	58.42	5.71	0.57	0.00	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	301.03	29.20	3.14	1.48	2.59	2.40
myeloma cell line:PCM6	10474-106I6	161.49	11.66	1.78	0.00	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	49.71	1.01	1.52	1.52	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	89.44	4.71	1.18	1.77	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	80.11	3.23	5.01	1.67	0.45	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	71.78	2.06	3.82	1.84	0.37	0.22
nasal epithelial cells, donor2	12227-129F4	55.75	7.18	4.42	1.10	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	98.70	3.91	4.14	1.61	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	48.64	6.36	2.25	2.25	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	90.05	11.81	3.37	3.59	1.69	0.84
neuroblastoma cell line:NH-12	10555-107I6	177.41	4.66	6.34	8.20	0.93	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	114.82	4.74	0.24	0.00	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	193.38	10.61	2.06	1.43	1.43	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	166.84	10.67	1.01	2.82	1.21	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	88.37	5.72	3.81	1.27	0.64	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	54.03	2.93	2.66	4.52	1.60	1.06
neutrophil PMN, donor1	12133-128D9	29.75	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	146.09	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	189.41	11.50	1.86	0.51	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	52.83	5.60	5.60	4.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	106.76	9.30	2.89	0.64	1.60	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	94.86	7.62	1.05	1.84	1.84	1.31
nucleus accumbens, adult, pool1	10037-101F1	47.43	2.06	1.12	1.31	0.00	0.28
occipital cortex - adult, donor10196	10172-103C1	18.54	0.00	6.18	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	67.36	2.15	1.34	0.27	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	42.58	1.46	0.00	1.82	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	66.65	3.67	2.62	1.57	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	103.41	3.86	2.57	0.86	0.43	0.00
occipital pole, adult, pool1	10036-101E9	46.44	2.05	1.10	1.58	0.63	0.32
olfactory region, adult	10195-103E6	46.81	2.87	0.76	0.57	0.19	0.19
optic nerve, donor1	10277-104E7	44.02	4.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	154.80	8.43	6.15	3.30	0.80	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	242.90	9.75	13.88	4.12	0.41	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	131.23	8.47	1.52	1.52	1.02	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	144.85	3.81	1.50	0.58	0.92	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	59.68	4.12	2.35	2.06	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	72.88	0.93	2.80	1.87	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	474.16	26.72	8.27	8.48	3.18	4.03
ovary, adult, pool1	10020-101D2	252.36	4.37	0.44	0.09	0.17	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	48.95	3.67	3.12	2.20	0.55	0.18
pancreas, adult, donor1	10049-101G4	656.57	0.94	7.53	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	156.82	3.91	1.68	1.12	0.56	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	189.60	8.01	0.68	2.21	0.68	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	91.24	1.49	0.50	0.17	0.33	0.83
paracentral gyrus, adult, pool1	10035-101E8	43.84	2.47	1.37	1.28	0.37	0.64
parietal cortex, adult, donor10258	10373-105G4	34.50	1.47	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	31.98	0.94	0.94	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	39.62	2.57	1.14	1.14	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	45.47	1.23	1.23	0.88	0.18	0.09
parietal lobe, fetal, donor1	10072-101I9	99.89	4.85	3.88	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	40.38	1.50	0.37	1.87	0.37	0.00
parotid gland, adult	10199-103F1	339.78	8.63	2.47	0.00	0.00	0.00
penis, adult	10200-103F2	184.77	10.74	0.00	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	244.88	11.16	3.16	5.58	0.37	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	136.66	12.24	3.93	3.35	2.48	1.75
pineal gland - adult, donor10196	10179-103C8	23.22	3.23	1.94	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	46.78	2.96	0.59	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	28.22	2.51	1.88	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	51.60	7.08	5.06	5.06	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	102.67	5.21	3.65	3.13	1.56	0.00
pituitary gland, adult, donor10258	10378-105G9	79.17	2.55	2.55	5.11	1.70	0.00
placenta, adult, pool1	10021-101D3	84.17	3.01	0.32	0.11	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	205.00	14.17	1.46	1.19	0.53	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	61.17	1.25	0.47	0.00	0.00	0.31
pons, adult, pool1	10033-101E6	43.29	1.81	1.03	1.20	1.03	0.34
postcentral gyrus, adult, pool1	10032-101E5	54.14	2.70	1.92	0.35	0.26	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	46.01	0.00	2.09	0.00	2.09	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	264.39	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	211.24	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	109.10	11.36	5.54	1.46	1.31	1.60
prostate cancer cell line:PC-3	10439-106E7	202.92	15.97	16.70	4.90	2.54	1.27
prostate, adult, pool1	10022-101D4	198.89	3.26	0.09	0.09	0.45	0.27
putamen, adult, donor10196	10176-103C5	36.83	1.65	1.18	1.18	0.71	0.24
putamen, adult, donor10252	10152-102I8	49.02	1.96	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	27.32	2.19	2.19	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	46.15	2.66	0.72	0.72	0.48	0.24
putamen, newborn, donor10223	10365-105F5	83.96	1.50	2.25	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	107.65	5.24	1.16	0.58	0.29	0.00
rectum, fetal, donor1	10067-101I4	123.80	8.35	4.17	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.61	2.76	0.64	0.21	0.64	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	67.10	1.66	12.43	3.73	0.00	0.00
retina, adult, pool1	10030-101E3	170.67	5.77	0.30	0.20	0.80	0.20
retinoblastoma cell line:Y79	10475-106I7	63.91	8.57	3.38	0.52	2.34	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	83.48	5.53	2.83	2.58	0.86	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	277.54	11.81	2.53	0.28	0.56	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	69.72	3.03	0.00	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	115.08	6.31	5.66	5.66	0.49	0.16
salivary acinar cells, donor2	11772-123I8	175.55	6.06	5.23	2.75	0.83	0.41
salivary acinar cells, donor3	11773-123I9	64.22	3.31	2.65	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	268.25	4.58	1.14	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	110.53	13.41	2.11	1.43	0.76	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	88.63	11.05	2.59	1.65	0.35	0.24
seminal vesicle, adult	10201-103F3	124.33	7.94	4.76	2.12	2.12	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	197.98	9.23	2.19	4.13	1.70	3.89
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	87.57	5.03	1.51	0.25	1.76	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	54.19	9.03	0.00	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	303.83	3.76	0.27	0.13	1.34	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	126.33	5.19	0.66	0.55	0.44	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	126.19	3.48	1.29	0.65	0.39	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	70.93	2.84	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	232.08	5.16	0.12	0.24	0.60	0.12
skeletal muscle, fetal, donor1	10066-101I3	315.58	5.03	1.01	3.02	1.01	1.01
skin, adult, donor1	10074-102A2	135.70	0.00	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	117.41	1.89	2.52	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	37.02	3.34	0.67	1.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	112.53	4.73	2.21	2.84	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	106.20	18.12	7.32	3.28	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	121.97	10.38	3.30	0.49	1.15	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	114.36	9.33	1.45	1.93	0.16	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	63.41	4.58	4.36	2.18	0.22	0.44
small intestine, adult, pool1	10024-101D6	151.81	4.06	0.72	0.00	0.48	0.24
small intestine, fetal, donor1	10064-101I1	112.53	5.90	1.97	0.49	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.75	3.08	0.51	2.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	155.59	1.55	0.78	0.00	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	14.21	2.14	3.75	0.27	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	48.86	2.52	0.92	1.38	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	65.45	1.58	0.39	1.18	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	43.58	2.77	0.00	1.38	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	89.65	3.66	1.83	3.66	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	102.40	0.92	1.84	2.30	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	64.97	3.88	2.09	1.79	0.60	0.15
spleen, adult, pool1	10025-101D7	154.96	5.29	0.22	0.11	0.33	0.00
spleen, fetal, pool1	10044-101F8	148.74	6.04	0.24	0.08	0.64	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	70.18	6.11	0.72	0.52	0.41	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	39.68	3.61	1.33	0.19	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	119.16	13.63	1.75	0.35	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	179.44	4.69	3.52	3.13	0.39	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	238.06	10.36	5.63	6.87	1.80	2.93
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	107.17	4.66	2.54	1.27	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	78.69	7.62	0.85	0.85	0.42	0.42
stomach, fetal, donor1	10062-101H8	79.03	5.34	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	251.80	5.13	1.71	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	75.81	1.25	0.83	0.83	1.25	0.21
substantia nigra, adult, donor10258	10371-105G2	29.48	2.59	0.52	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	72.78	0.71	2.12	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	86.66	7.11	4.81	1.83	0.69	1.38
temporal lobe, adult, pool1	10031-101E4	59.42	3.90	1.61	0.51	0.42	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	74.79	6.41	2.14	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	62.85	2.64	0.88	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	111.71	4.54	3.49	2.09	0.35	0.35
tenocyte, donor2	11765-123I1	114.83	6.49	2.29	0.00	0.38	0.38
tenocyte, donor3	11768-123I4	88.96	5.56	4.08	2.59	0.74	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	76.65	19.38	6.63	1.53	3.23	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	88.64	6.94	0.62	0.92	0.31	0.77
teratocarcinoma cell line:PA-1	10807-111A6	112.05	7.75	4.34	0.93	0.77	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	106.64	10.03	6.35	2.16	1.52	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	114.59	9.08	4.54	1.51	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	93.68	5.34	9.82	4.14	1.31	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	260.24	10.10	4.89	3.91	2.61	1.30
testis, adult, pool1	10026-101D8	120.79	6.55	0.43	0.11	0.75	0.21
testis, adult, pool2	10096-102C6	67.66	9.47	0.90	1.35	1.80	1.35
thalamus - adult, donor10196	10168-103B6	34.22	1.10	3.31	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	78.77	1.88	0.94	0.63	1.25	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	0.00	1.54	1.54	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.96	1.15	2.14	2.96	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	23.59	0.58	0.00	1.73	0.58	0.00
throat, adult	10209-103G2	172.52	5.24	2.25	0.00	0.50	0.00
throat, fetal, donor1	10061-101H7	106.95	3.96	2.13	1.22	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	164.35	7.95	7.55	4.37	0.40	1.19
thymus, adult, pool1	10027-101D9	210.06	9.15	0.10	0.30	0.70	0.20
thymus, fetal, pool1	10043-101F7	187.13	5.51	0.31	0.42	0.21	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	182.82	11.57	2.26	2.53	1.20	2.13
thyroid carcinoma cell line:TCO-1	10783-110G9	170.84	11.73	3.91	3.21	0.70	0.70
thyroid, adult, pool1	10028-101E1	235.62	4.85	0.47	0.09	1.49	0.28
thyroid, fetal, donor1	10060-101H6	102.30	5.80	0.53	0.00	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	3.08	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	193.97	5.81	0.93	0.23	1.40	0.70
tongue, fetal, donor1	10059-101H5	169.85	4.34	1.18	1.58	0.79	0.79
tonsil, adult, pool1	10047-101G2	253.44	9.82	0.50	0.10	0.20	0.50
trachea, adult, pool1	10029-101E2	160.08	7.36	0.82	0.33	0.74	0.41
trachea, fetal, donor1	10058-101H4	119.26	3.85	0.77	1.15	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	108.41	8.86	2.48	3.90	0.35	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	137.89	8.61	1.93	0.51	1.22	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	168.13	15.20	8.30	3.60	0.47	0.16
tridermal teratoma cell line:HGRT	10694-109G1	34.25	1.90	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	153.47	8.55	3.13	0.93	1.02	0.68
umbilical cord, fetal, donor1	10057-101H3	106.41	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	200.32	3.07	0.34	0.00	0.34	0.17
uterus, fetal, donor1	10055-101H1	123.89	6.14	1.02	1.02	0.51	0.00
vagina, adult	10204-103F6	231.99	0.65	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	197.06	6.58	0.44	0.00	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	114.83	8.81	0.80	0.53	0.53	0.00